| Dermal Photo Allergic Skin Reaction (NCT04070755) | Vyne Therapeutics Inc. | 2016-09-21 |
| Pharmacokinetics and Safety of BI 695501 (NCT02899338) | Boehringer Ingelheim | 2016-09-21 |
| A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma (NCT02852655) | Dana-Farber Cancer Institute | 2016-09-21 |
| Immediate Post-placental Insertion of IUCD During Cesarean Delivery Versus 6 Week Post-Cesarean Insertion (NCT03404622) | ALshaimaa Aboalhassan Ali | 2016-09-20 |
| Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma (NCT02862535) | Gilead Sciences | 2016-09-20 |
| Treg Therapy in Subclinical Inflammation in Kidney Transplantation (NCT02711826) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-09-20 |
| A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC) (NCT02859324) | Celgene | 2016-09-20 |
| Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors (NCT02909452) | Syndax Pharmaceuticals | 2016-09-20 |
| Bioequivalence Study of CJ-30061 in Healthy Male Volunteers (NCT03657472) | HK inno.N Corporation | 2016-09-19 |
| A Study to Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers (NCT02910635) | Ionis Pharmaceuticals, Inc. | 2016-09-19 |
| Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin (NCT04330677) | University Hospital, Bonn | 2016-09-18 |
| Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis (NCT02801435) | Betta Pharmaceuticals Co., Ltd. | 2016-09-17 |
| Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole (NCT03038308) | Columbia University | 2016-09-16 |
| Safety, Tolerability and Pharmacokinetics of BI 1026706 in Healthy Chinese and Japanese Male Volunteers (NCT02652416) | Boehringer Ingelheim | 2016-09-16 |
| This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis (NCT02772601) | AbbVie | 2016-09-15 |
| X4P-001 and Pembrolizumab in Patients With Advanced Melanoma (NCT02823405) | X4 Pharmaceuticals | 2016-09-15 |
| A Study of Single and Repeated Doses of LY3556050 in Healthy Participants (NCT05341102) | Eli Lilly and Company | 2016-09-14 |
| Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis (NCT02864264) | Bristol-Myers Squibb | 2016-09-14 |
| Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases (NCT02288000) | University Hospital, Lille | 2016-09-14 |
| A Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors (NCT02799095) | Mural Oncology, Inc | 2016-09-14 |
| Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors (NCT02903914) | Incyte Corporation | 2016-09-14 |
| Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201) (NCT02894385) | Bayer | 2016-09-13 |
| SJ733 Induced Blood Stage Malaria Challenge Study (NCT02867059) | Medicines for Malaria Venture | 2016-09-13 |
| Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE) (NCT02080195) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-09-13 |
| Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma (NCT02520791) | National Cancer Institute (NCI) | 2016-09-13 |
| A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335 (NCT02894905) | Janssen Research & Development, LLC | 2016-09-13 |
| DHEA in Synovial Sarcoma Patients (NCT02683148) | Washington University School of Medicine | 2016-09-13 |
| Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001 (NCT02868229) | Novo Nordisk A/S | 2016-09-12 |
| A Study to Evaluate the Pharmacokinetics and the Effect on Cardiac Repolarization of Odalasvir Administered as a Single Dose Tablet Under Fed Conditions in Healthy Participants (NCT02889367) | Janssen Research & Development, LLC | 2016-09-12 |
| 18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer (NCT02809690) | University of Southern California | 2016-09-12 |
| PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States (NCT02773979) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-09-12 |
| A Study to Evaluate if AC-084 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects (NCT02905253) | Idorsia Pharmaceuticals Ltd. | 2016-09-12 |
| CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer (NCT02861300) | David Bajor, MD | 2016-09-12 |
| A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy Participants (NCT02906813) | Takeda | 2016-09-12 |
| Dose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge Strain (NCT02816346) | PATH | 2016-09-12 |
| A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors (NCT02836600) | Eli Lilly and Company | 2016-09-09 |
| Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet (NCT02902107) | Memorial Sloan Kettering Cancer Center | 2016-09-09 |
| First in Patient Study for PF-06840003 in Malignant Gliomas (NCT02764151) | Pfizer | 2016-09-09 |
| A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design (NCT04052711) | Vyne Therapeutics Inc. | 2016-09-08 |
| Neuroendocrine Response to Oral Alcohol Administration (NCT03165942) | Yale University | 2016-09-08 |
| Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions (NCT03050164) | Hunan Kelun Pharmaceutical Co., Ltd. | 2016-09-08 |
| A Study to Determine the Excretion Balance, Pharmacokinetics, Metabolism and Absolute Oral Bioavailability of a Single Oral Dose of [14C]-Labeled Idasanutlin and an Intravenous Tracer Dose of [13C]-Labeled Idasanutlin in a Single Cohort of Participants With Solid Tumors (Malignancies) (NCT02828930) | Hoffmann-La Roche | 2016-09-08 |
| Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole (NCT02824042) | Bayer | 2016-09-07 |
| XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma (NCT02721459) | H. Lee Moffitt Cancer Center and Research Institute | 2016-09-07 |
| The Effect of Antioxidants on Skin Blood Flow During Local Heating (NCT03680638) | The University of Texas at Arlington | 2016-09-07 |
| Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium (NCT02831231) | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2016-09-07 |
| Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG (NCT02916979) | Dartmouth-Hitchcock Medical Center | 2016-09-06 |
| Clinical Study to Investigate the Systemic Exposure, Safety, and Local Tolerability of SJP002 Ophthalmic Solution in Healthy Male Volunteers (NCT02924155) | Samjin Pharmaceutical Co., Ltd. | 2016-09-05 |
| Viaskin Pertussis Vaccine Trial (NCT03035370) | DBV Technologies | 2016-09-05 |
| Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients (NCT02812706) | Sanofi | 2016-09-05 |
| Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus (NCT02872597) | University Hospitals Cleveland Medical Center | 2016-09-05 |
| TAK-438 Bismuth Drug Interaction Study (NCT02892409) | Takeda | 2016-09-05 |
| Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission (NCT02780401) | University of Washington | 2016-09-02 |
| A Study in Healthy Participants to Evaluate the Effect of JNJ-54175446 on Amyloid Biomarkers and Cytokine Profiles in Cerebrospinal Fluid and Plasma (NCT02933762) | Janssen Research & Development, LLC | 2016-09-01 |
| Effect of Elderberry Juice on Cognition and Inflammation in Patients With Mild Cognitive Impairment (NCT02414607) | University of Missouri-Columbia | 2016-09-01 |
| Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure (NCT02897063) | Vanderbilt University Medical Center | 2016-09-01 |
| Hookworm Therapy for Coeliac Disease (NCT02754609) | James Cook University, Queensland, Australia | 2016-09-01 |
| Subarachnoid Hemorrhage Recovery And Galantamine (NCT02872857) | The University of Texas Health Science Center, Houston | 2016-09-01 |
| A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer (NCT02874664) | Stemcentrx | 2016-09-01 |
| Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery (NCT02953587) | Vanderbilt University Medical Center | 2016-09-01 |
| A Study of LY3337641 in Healthy Male Participants (NCT02914379) | Eli Lilly and Company | 2016-09-01 |
| A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma (NCT02820584) | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 2016-09-01 |
| A Study of LY2510924 and Durvalumab in Participants With Solid Tumors (NCT02737072) | Eli Lilly and Company | 2016-09-01 |
| Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors (NCT02869217) | University Health Network, Toronto | 2016-09-01 |
| Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis (NCT02917681) | University of Sao Paulo General Hospital | 2016-09-01 |
| Muscle Anabolic Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients (NCT02990533) | The University of Texas Medical Branch, Galveston | 2016-09-01 |
| PET-CT/MRI in the Radiotherapy for Prostate Cancer (NCT02816840) | Xuzhou Medical University | 2016-09-01 |
| Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects (NCT02924337) | Poxel SA | 2016-09-01 |
| The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke (NCT03080454) | Northwell Health | 2016-09-01 |
| A Study of the Absorption, Distribution, Metabolism and Excretion of LY3039478 in Healthy Participants (NCT02917733) | Eli Lilly and Company | 2016-09-01 |
| An Insulin Sensitivity Study in Healthy Subjects (NCT02922426) | Alkermes, Inc. | 2016-09-01 |
| Atomoxetine and Oxybutynin in Obstructive Sleep Apnea (NCT02908529) | Brigham and Women's Hospital | 2016-09-01 |
| Immunogenicity and Pharmacodynamic of B12019 and Neulasta® in Healthy Subjects (NCT02912377) | Cinfa Biotech | 2016-09-01 |
| RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults. (NCT02864628) | Bavarian Nordic | 2016-09-01 |
| An Open Label, Phase 1b, Ascending Dose Study of DM199 (NCT02868996) | DiaMedica Therapeutics Inc | 2016-09-01 |
| A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder (NCT02905227) | Acorda Therapeutics | 2016-09-01 |
| Comparison of the Ganglionated Plexi Activity in Patients With Different Forms of Atrial Fibrillation Guided by SUMO Technology (NCT02914860) | Meshalkin Research Institute of Pathology of Circulation | 2016-09-01 |
| Study of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Refractory and Relapsed Multiple Myeloma (NCT03196414) | The First Affiliated Hospital of Soochow University | 2016-09-01 |
| Metformin Immunotherapy in HIV Infection (NCT02659306) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2016-09-01 |
| Nutrition, Oral Health and Type 2 Diabetes (NCT02916589) | Kristianstad University | 2016-09-01 |
| A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects (NCT02922452) | Bristol-Myers Squibb | 2016-09-01 |
| Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers (NCT02922465) | Kowa Research Institute, Inc. | 2016-09-01 |
| Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women (NCT02940522) | AMAG Pharmaceuticals, Inc. | 2016-09-01 |
| The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers (NCT02926326) | Mereo BioPharma | 2016-09-01 |
| Genetics of Response to Canagliflozin (NCT02891954) | University of Maryland, Baltimore | 2016-09-01 |
| Influence of SLCO2B1 Polymorphism on the PK of Voriconazole in CYP2C19 PM (NCT02906176) | Seoul National University Hospital | 2016-09-01 |
| A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function (NCT02871570) | GlycoMimetics Incorporated | 2016-09-01 |
| Bioequivalence Study of Idalopirdine in Healthy Subjects (NCT02894515) | H. Lundbeck A/S | 2016-09-01 |
| Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging (NCT02877758) | Tomorrowlabs GmbH | 2016-09-01 |
| DC1s-CTL Cellular Therapy for Renal Cell Carcinoma (NCT02787915) | Xuzhou Medical University | 2016-09-01 |
| PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma (NCT02892695) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2016-09-01 |
| Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia (NCT02905994) | Massachusetts General Hospital | 2016-09-01 |
| Dermal Cumulative Irritant Patch Study (NCT04064125) | Vyne Therapeutics Inc. | 2016-09-01 |
| An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers (NCT02648490) | Henlix, Inc | 2016-09-01 |
| Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPM (NCT02838745) | Baylor College of Medicine | 2016-09-01 |
| Single and Multiple Dose Evaluation of QBKPN SSI In Healthy Volunteers (NCT02897999) | Qu Biologics Inc. | 2016-09-01 |
| An Open-Label, 2 Treatment Period,Study To Study The Drug Interaction Between Repeated Doses Of Itraconazole And Single Dose Pharmacokinetics (PK) Of PF-06648671 In Healthy Adults. (NCT02883114) | Pfizer | 2016-09-01 |
| Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas (NCT02978261) | Beijing Pearl Biotechnology Limited Liability Company | 2016-09-01 |
| Single Ascending Dose Study of TD-1439 in Healthy Subjects (NCT02903095) | Theravance Biopharma | 2016-09-01 |
| Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides (NCT02900027) | Ionis Pharmaceuticals, Inc. | 2016-09-01 |